End-to-End Program

Scientific Project Management — We Lead With Your Priorities in Mind

A Seamless Experience, Thanks to Expert Scientific Project Management

From lead candidate selection to clinical proof of concept, whether for a single study or multiple programs, Altasciences’ Scientific Project Management team manages every study with your business priorities in mind.

Join Lauren Szczurowski, Executive Director of Scientific Project Management, in this on-demand podcast as she reveals how Altasciences makes outsourcing early phase drug development a seamless experience.

Listen to Podcast

Schedule a conversation with one of our Scientific Project Managers to review your questions and requirements.

You may also be interested in the following:

Video: The Benefits of Tell Us Once™
Video: Your Road to Proactive Development with Altasciences
Fact Sheet: First-in-Human Trial Capabilities
Webpage: Full-Time Equivalent Capabilities

Video — A Seamless CRO Experience

At Altasciences, our integrated, full-service solutions from lead candidate selection to clinical proof of concept are all customizable to your specific needs.

Watch as Ingrid Holmes, Vice President, Global Clinical Operations, discusses how we help sponsors bring better drugs to market, faster.

Contact our experts to learn more about our integrated drug development solutions.

The Right Strategy for your Small Molecule Program

Did you know that, in addition to large molecule work, Altasciences' preclinical team has extensive experience in designing and conducting safety assessment programs for small molecules? Our solutions meet all regulatory requirements, and include IND/NDA-enabling toxicology, safety pharmacology, and laboratory services in both rodent and non-rodent species.

Choose Altasciences for your small molecule safety assessment program and let us guide you seamlessly through each milestone.

The right CRO for your preclinical and clinical biosimilar studies

Companies developing biosimilars are collaborating with us because of our firsthand preclinical and clinical experience, distinctive recruitment strategies and speed in conducting biosimilar studies that require a customized approach based on the therapeutic indication and study-specific goals.

We have the scientific, toxicological, medical, and bioanalytical know-how to design studies that meet your objectives and timelines, manage any associated risks, and develop the methods required to analyze your product and its potential immunogenicity.

How we help move your biosimilar programs forward:

	Customized workflows using LC-MS/MS or Ligand Binding bioanalytical platforms for preclinical and clinical samples
	Method development, GCP/GLP-compliant biosimilar assay development validation, and sample analysis for PK and immunogenicity/anti-drug antibody testing
	Comparative general toxicity and PK studies in multiple species
	Supplemental assessments such as for immunogenicity can be included in general toxicology study designs or as individual projects, depending on the nature of the test article
	Ability to run multiple biosimilar programs simultaneously across our three clinical pharmacology units
	Rapid recruitment and retention of up to 250 subjects per clinical pharmacology trial
	Pharmacodynamic assessments required for biosimilars ranging from measurements in blood to performing glucose or insulin clamps

View our issue of The Altascientist on the topic and contact one of our experts to learn how we can help with your biosimilar programs.

BOOK A CONSULT

Supporting your Large Molecules ― from Discovery to Preclinical to Clinical Pharmacology

Altasciences recently expanded its bioanalytical laboratory by adding space dedicated to ligand binding and cell-based assays, to continue to support and deliver quality bioanalytical solutions to our clients. The new, larger space is fully equipped to respond to the high demand of cell-based neutralization and functional assays for biologics and vaccines. We now have the additional capacity for cell lineage and functional immuno-phenotyping by flow cytometry to support both preclinical and clinical studies.

Bioanalytical Support for Your Large Molecules

Renowned for our vast experience in LC-MS/MS and Ligand Binding bioanalytical platforms, our team of dedicated scientists in both the U.S. and Canada provide a comprehensive suite of bioanalytical services, from discovery to preclinical to phase IV. They evaluate each request and provide customized workflows to allow accurate quantitation using the appropriate platforms (Mass Spectrometry and/or Ligand Binding).

Why do clients appreciate working with us? Because each bioanalytical phase of your study ― method development, validation, and sample analysis ― has a Method Development Expert and/or a Bioanalytical Principal Investigator with the appropriate scientific and regulatory expertise assigned.

Let's discuss your bioanalytical needs and how our solutions can support your preclinical and/or clinical research.

Subscribe to End-to-End Program